Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma

Table 1 Baseline and tumor characteristics of the study patients

	Liver resection group	TACE group	P value
	218	281
Age (yr)	52.1 ± 12.5	52.0 ± 13.5	0.950
Sex (M/F)	162/56	210/71	0.915
Weight (kg)	67.6 ± 9.5	66.8 ± 9.4	0.358
Height (cm)	165.5 ± 8.7	164.9 ± 9.0	0.496
BMI (kg/m2)	23.6 ± 2.5	23.6 ± 2.4	0.870
Cirrhosis etiology (HBV/HCV/negative/other)	193/5/9/11	256/6/6/13	0.352
MELD score	5.4 ± 1.8	5.5 ± 1.7	0.607
Child score (A/B/C)	162/56/0	222/59/0	0.218
EOCG score (0/1/2)	161/29/28	211/39/31	0.697
PHT (yes/no)	182/36	244/37	0.668
Tumor diameter of the largest target (cm)	6.2 ± 2.3	7.6 ± 2.2	< 0.001
AFP level (ng/mL)	2388.5 ± 7916.0	2650.1 ± 8514.4	0.726
0-400 ng/mL	120	136
400-800 ng/mL	11	26
800-1200 ng/mL	15	13
≥ 1210 ng/mL	72	106
NLR ≥ 4 (yes/no)	109/109	160/121	0.123
Obvious arterial phase enhancement (yes/no)	175/43	222/59	0.727
Diagnostic method (enhanced CT/MRI/biopsy)	172/36/10	238/27/16	0.127

BMI: Body mass index; HBV: Hepatitis B virus; HCV: Hepatitis C virus; MELD: Model for end stage liver disease; TACE: Transarterial chemoembolization; LT: Liver transplantation; NLR: Neutrophil-lymphocyte ratio; CT: Computed tomography; MRI: Magnetic resonance imaging; M: Male; F: Female.